Related Experiment Videos
[Shortest possible muscle relaxation in children using atracurium and/or vecuronium]
J Hausdörfer1, V Krahn, K Baldewein
1Abteilung Anästhesie III, Medizinischen Hochschule Hannover.
Insights
A study on intubation anesthesia in children found that minimal doses of atracurium or vecuronium provide excellent intubation conditions. These muscle relaxants offer short relaxation times, presenting a viable alternative to succinylcholine.
Area of Science:
- Anesthesiology
- Pediatric Anesthesia
- Pharmacology
Background:
- Intubation anesthesia in pediatric patients requires effective muscle relaxation.
- Succinylcholine, while effective, has significant side effects.
- Non-depolarizing muscle relaxants are increasingly considered for pediatric use.
Purpose of the Study:
- To evaluate the impact of atracurium and vecuronium on intubation anesthesia in infants and children.
- To assess the efficacy of low-dose priming techniques with these agents.
- To compare their effectiveness against traditional methods.
Main Methods:
- Intra-individual evaluation using accelerography to monitor neuromuscular blockade.
- Administration of a priming dose followed by a main dose of either atracurium or vecuronium.
- Assessment of intubation conditions in pediatric patients undergoing elective or minor surgery.
Main Results:
- Both atracurium and vecuronium, at minimal priming doses, resulted in good to very good intubation conditions.
- These agents provided very short relaxation times, comparable to succinylcholine.
- Combination therapy with a priming technique did not offer clinically significant advantages.
Conclusions:
- Low-dose atracurium and vecuronium are effective and safe alternatives for intubation anesthesia in pediatric patients.
- These agents offer rapid onset and short duration of action, suitable for short procedures.
- They represent a favorable alternative to succinylcholine, given its side effect profile.
Abstract:
The aim of this study was to monitor accelographically the impact of atracurium (A) and/or vecuronium (V) on intubation anaesthesia in infants and/or children for elective surgery or minor short-term surgery. An intra-individual evaluation is valid even though a very practical but less established monitoring method is used. Infants receiving a "priming"-dose of V 0.01 mg kg-1 BW or A 0.05 mg kg-1 BW followed 3 minutes later by a main dose of V 0.04 mg kg-1 BW or A 0.2 mg kg-1 BW were found to be in good or even very good intubation condition. These minimal doses afforded very short relaxation times, which are next in line to succinylcholin. A combination of V and A in the "priming"-technique did not lead to better conditions of any clinical relevance. Medium range non-depolarising muscle blockers, as they are available to the pediatric anesthetist nowadays, seem to compare favourable with the use of succinylcholin, which is to be considered an obsolete drug due to its various side effects.